Verena Steinke‐Lange

3.8k total citations
31 papers, 142 citations indexed

About

Verena Steinke‐Lange is a scholar working on Pathology and Forensic Medicine, Cancer Research and Oncology. According to data from OpenAlex, Verena Steinke‐Lange has authored 31 papers receiving a total of 142 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 14 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Verena Steinke‐Lange's work include Genetic factors in colorectal cancer (21 papers), Cancer Genomics and Diagnostics (14 papers) and Colorectal Cancer Treatments and Studies (6 papers). Verena Steinke‐Lange is often cited by papers focused on Genetic factors in colorectal cancer (21 papers), Cancer Genomics and Diagnostics (14 papers) and Colorectal Cancer Treatments and Studies (6 papers). Verena Steinke‐Lange collaborates with scholars based in Germany, Netherlands and Austria. Verena Steinke‐Lange's co-authors include Elke Holinski‐Feder, Andreas Laner, Monika Morak, Anna Benet‐Pagès, Markus Rentsch, Maike de Wit, Ulrich Mansmann, Stefan Aretz, C. Haberl and H. Vogelsang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Cancer.

In The Last Decade

Verena Steinke‐Lange

26 papers receiving 142 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Verena Steinke‐Lange Germany 8 83 67 53 43 34 31 142
Sami Belhadj Spain 8 46 0.6× 70 1.0× 79 1.5× 53 1.2× 51 1.5× 8 157
Wendy A. van Zelst-Stams Netherlands 5 58 0.7× 72 1.1× 87 1.6× 53 1.2× 45 1.3× 5 168
Christine Lasset France 3 64 0.8× 50 0.7× 70 1.3× 46 1.1× 55 1.6× 3 132
Paula Rofes Spain 6 35 0.4× 48 0.7× 65 1.2× 52 1.2× 30 0.9× 11 118
Olga Campos Spain 9 96 1.2× 100 1.5× 138 2.6× 129 3.0× 67 2.0× 18 270
Scott Shooter United Kingdom 2 98 1.2× 31 0.5× 76 1.4× 27 0.6× 34 1.0× 3 129
Sebastian DiLorenzo Sweden 5 59 0.7× 19 0.3× 59 1.1× 36 0.8× 27 0.8× 7 127
Laura Mudie United Kingdom 3 152 1.8× 45 0.7× 77 1.5× 24 0.6× 62 1.8× 3 172
Baptiste Brault France 4 116 1.4× 71 1.1× 133 2.5× 183 4.3× 62 1.8× 5 271
Kavitta Sivanandan Sweden 4 53 0.6× 28 0.4× 149 2.8× 66 1.5× 76 2.2× 4 201

Countries citing papers authored by Verena Steinke‐Lange

Since Specialization
Citations

This map shows the geographic impact of Verena Steinke‐Lange's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verena Steinke‐Lange with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verena Steinke‐Lange more than expected).

Fields of papers citing papers by Verena Steinke‐Lange

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verena Steinke‐Lange. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verena Steinke‐Lange. The network helps show where Verena Steinke‐Lange may publish in the future.

Co-authorship network of co-authors of Verena Steinke‐Lange

This figure shows the co-authorship network connecting the top 25 collaborators of Verena Steinke‐Lange. A scholar is included among the top collaborators of Verena Steinke‐Lange based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verena Steinke‐Lange. Verena Steinke‐Lange is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lucas, Morghan C., T. Keßler, Verena Steinke‐Lange, et al.. (2025). A series of reviews in familial cancer: genetic cancer risk in context variants of uncertain significance in MMR genes: which procedures should be followed?. Familial Cancer. 24(2). 42–42. 1 indexed citations
2.
3.
Steinke‐Lange, Verena & Elke Holinski‐Feder. (2024). Lynch-Syndrom. 19(1). 50–59. 1 indexed citations
4.
5.
Steinke‐Lange, Verena & Elke Holinski‐Feder. (2024). Lynch-Syndrom. PubMed. 45(4). 290–299. 1 indexed citations
6.
Keßler, T., B. Liesfeld, Simon von Ameln, et al.. (2023). Impact of cfDNA Reference Materials on Clinical Performance of Liquid Biopsy NGS Assays. Cancers. 15(20). 5024–5024. 5 indexed citations
7.
Steinke‐Lange, Verena, et al.. (2023). Transcript capture and ultradeep long-read RNA sequencing (CAPLRseq) to diagnose HNPCC/Lynch syndrome. Journal of Medical Genetics. 60(8). 747–759. 10 indexed citations
8.
Henkel, Jan, Andreas Laner, Kerstin Becker, et al.. (2023). Diagnostic yield and clinical relevance of expanded germline genetic testing for nearly 7000 suspected HBOC patients. European Journal of Human Genetics. 31(8). 925–930. 6 indexed citations
9.
Morak, Monika, Marta Pineda, Alexandra Martins, et al.. (2022). Splicing analyses for variants in MMR genes: best practice recommendations from the European Mismatch Repair Working Group. European Journal of Human Genetics. 30(9). 1051–1059. 5 indexed citations
10.
Neuhann, Teresa, Verena Steinke‐Lange, Andreas Laner, et al.. (2022). Highly sensitive liquid biopsy Duplex sequencing complements tissue biopsy to enhance detection of clinically relevant genetic variants. Frontiers in Oncology. 12. 1014592–1014592. 5 indexed citations
11.
Steinke‐Lange, Verena, H. Vogelsang, Markus Rentsch, et al.. (2022). Clinical Validity of Circulating Tumor DNA as Prognostic and Predictive Marker for Personalized Colorectal Cancer Patient Management. Cancers. 14(3). 851–851. 7 indexed citations
12.
Neuhann, Teresa, et al.. (2022). Long-term chemoprevention in patients with adenomatous polyposis coli: an observational study. Familial Cancer. 21(4). 463–472. 6 indexed citations
13.
Morak, Monika, Alex Hastie, Andreas Laner, et al.. (2021). Constitutional chromothripsis of the APC locus as a cause of genetic predisposition to colon cancer. Journal of Medical Genetics. 59(10). 976–983. 12 indexed citations
14.
Benet‐Pagès, Anna, et al.. (2021). Liquid Biopsy Hotspot Variant Assays: Analytical Validation for Application in Residual Disease Detection and Treatment Monitoring. Clinical Chemistry. 67(11). 1483–1491. 7 indexed citations
15.
Steinke‐Lange, Verena, Robin De Putter, Elke Holinski‐Feder, & Kathleen Claes. (2021). Somatic mosaics in hereditary tumor predisposition syndromes. European Journal of Medical Genetics. 64(12). 104360–104360. 7 indexed citations
16.
Perne, Claudia, Verena Steinke‐Lange, Stefan Aretz, & Isabel Spier. (2020). Seltene Tumoren als Leitsymptom hereditärer Tumorsyndrome. Der Pathologe. 41(5). 535–549. 2 indexed citations
17.
Morak, Monika, Verena Steinke‐Lange, Anna Benet‐Pagès, et al.. (2020). Prevalence of CNV-neutral structural genomic rearrangements in MLH1, MSH2, and PMS2 not detectable in routine NGS diagnostics. Familial Cancer. 19(2). 161–167. 9 indexed citations
18.
Steinke‐Lange, Verena & Elke Holinski‐Feder. (2019). Genetic Screening and Personalized Prevention in Colorectal Cancer. Visceral Medicine. 35(4). 226–230. 3 indexed citations
19.
Vangala, Deepak, Christian Pox, Christoph Engel, et al.. (2018). Value of EGD for gastric cancer surveillance in patients with hereditary non-polyposis colorectal cancer (HNPCC) or Lynch syndrome (LS).. Journal of Clinical Oncology. 36(15_suppl). 1522–1522. 3 indexed citations
20.
Vangala, Deepak, Christian Pox, Christoph Engel, et al.. (2018). Clinical characteristics and EGD surveillance in Lynch-syndrome patients with small bowel/duodenal carcinomas.. Journal of Clinical Oncology. 36(15_suppl). 1555–1555. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026